Issue navigation
Volume 120, Issue 10, July 2024
Cardiovascular Research Onlife
Clinical Commentaries
Zilebesiran, a ribonucleic acid interference agent targeting angiotensinogen, proves a promising approach in hypertension
Cardiovascular Research, Volume 120, Issue 10, July 2024, Pages e41–e43, https://doi.org/10.1093/cvr/cvae140
Editorials
The ketogenic diet is unable to improve cardiac function in ischaemic heart failure: an unexpected result?
Cardiovascular Research, Volume 120, Issue 10, July 2024, Pages 1097–1099, https://doi.org/10.1093/cvr/cvae126
The significant impact of experimental variables on the gut microbiome
Cardiovascular Research, Volume 120, Issue 10, July 2024, Pages 1100–1101, https://doi.org/10.1093/cvr/cvae119
Novel thrombolytic treatments of acute ischaemic stroke, choosing the right safety belt to drive this car
Cardiovascular Research, Volume 120, Issue 10, July 2024, Pages 1102–1103, https://doi.org/10.1093/cvr/cvae127
Research Letter
Association between cumulative uric acid exposure and the risk of incident cardiac conduction block
Cardiovascular Research, Volume 120, Issue 10, July 2024, Pages 1104–1106, https://doi.org/10.1093/cvr/cvae115
Review
Advances in nucleic acid-targeted therapies for cardiovascular disease prevention
Cardiovascular Research, Volume 120, Issue 10, July 2024, Pages 1107–1125, https://doi.org/10.1093/cvr/cvae136
Original Articles
Cardiac remodelling and heart failure
The ketogenic diet does not improve cardiac function and blunts glucose oxidation in ischaemic heart failure
Cardiovascular Research, Volume 120, Issue 10, July 2024, Pages 1126–1137, https://doi.org/10.1093/cvr/cvae092
Activated factor X stimulates atrial endothelial cells and tissues to promote remodelling responses through AT1R/NADPH oxidases/SGLT1/2
Cardiovascular Research, Volume 120, Issue 10, July 2024, Pages 1138–1154, https://doi.org/10.1093/cvr/cvae101
Co-morbidites and cardiovascular disease
Influence of angiotensin II on the gut microbiome: modest effects in comparison to experimental factors
Cardiovascular Research, Volume 120, Issue 10, July 2024, Pages 1155–1163, https://doi.org/10.1093/cvr/cvae062
Developmental cardiology
FLT4 causes developmental disorders of the cardiovascular and lymphovascular systems via pleiotropic molecular mechanisms
Cardiovascular Research, Volume 120, Issue 10, July 2024, Pages 1164–1176, https://doi.org/10.1093/cvr/cvae104
Imaging and novel technologies
Low-intensity pulsed ultrasound protects from inflammatory dilated cardiomyopathy through inciting extracellular vesicles
Cardiovascular Research, Volume 120, Issue 10, July 2024, Pages 1177–1190, https://doi.org/10.1093/cvr/cvae096
Thrombosis
A low bleeding risk thrombolytic agent: citPA5
Cardiovascular Research, Volume 120, Issue 10, July 2024, Pages 1191–1201, https://doi.org/10.1093/cvr/cvae060
Vascular pathophysiology
Adenosine kinase inhibition protects mice from abdominal aortic aneurysm via epigenetic modulation of VSMC inflammation
Cardiovascular Research, Volume 120, Issue 10, July 2024, Pages 1202–1217, https://doi.org/10.1093/cvr/cvae093
Role of endothelial Raptor in abnormal arteriogenesis after lower limb ischaemia in type 2 diabetes
Cardiovascular Research, Volume 120, Issue 10, July 2024, Pages 1218–1234, https://doi.org/10.1093/cvr/cvae105
Retraction
Retraction of: Transcription factor Krüppel-like factor 2 plays a vital role in endothelial colony forming cells differentiation
Cardiovascular Research, Volume 120, Issue 10, July 2024, Page 1235, https://doi.org/10.1093/cvr/cvae048
